Dyne Therapeutics Inc (NAS:DYN)
$ 26.71 +0.22 (+0.83%) Market Cap: 4.99 Bil Enterprise Value: 4.31 Bil PE Ratio: 0 PB Ratio: 6.30 GF Score: 34/100

Dyne Therapeutics, Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 20, 2026 / 03:00 PM GMT
Release Date Price: $17.56 (+10.30%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

DYN.OQ - Dyne Therapeutics, Inc
Dyne Therapeutics, Inc at RBC Capital Markets Global Healthcare Conference
May 20, 2026 / 03:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
All right. Great. Thanks. Hello, everybody. Luca Ace, Senior Biotech Analyst here at RBC Capital Market. Today is our great privilege to actually have Dine as part of our 2026 Global Healthcare Conference. Representing the company, we have Eric Closera, who is the Chief Financial Officer, as well as Ron Batra, Chief Scientific Officer. Thanks again, guys, for joining us. How are you guys doing today?

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good. Thank you for having us. It's a pleasure and honor to be here. Look forward to that discussion.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot